{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:45:25Z","timestamp":1760985925503,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,2]]},"DOI":"10.1182\/blood.2020005329","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T14:09:34Z","timestamp":1585922974000},"page":"1078-1080","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Tackling Burkitt when it\u2019s back"],"prefix":"10.1182","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-7636","authenticated-orcid":false,"given":"Aron","family":"Simkins","sequence":"first","affiliation":[{"name":"George Washington University Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieron","family":"Dunleavy","sequence":"first","affiliation":[{"name":"George Washington University Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"14","key":"2020040310083904000_B1","first-page":"1124","article-title":"Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy","volume":"135","author":"Woessmann","year":"2020","journal-title":"Blood"},{"issue":"4","key":"2020040310083904000_B2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2018-02-778480","article-title":"Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective","volume":"132","author":"Dunleavy","year":"2018","journal-title":"Blood"},{"issue":"22","key":"2020040310083904000_B3","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1182\/bloodadvances.2017008748","article-title":"Adolescent and young adult lymphoma: collaborative efforts toward optimizing care and improving outcomes","volume":"1","author":"Kahn","year":"2017","journal-title":"Blood Adv"},{"issue":"3","key":"2020040310083904000_B4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2020040310083904000_B5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"issue":"15","key":"2020040310083904000_B6","article-title":"Results of the randomized intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen [abstract]","volume":"34","author":"Minard-Colin","year":"2016","journal-title":"J Clin Oncol"},{"issue":"20","key":"2020040310083904000_B7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt\u2019s lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"issue":"19","key":"2020040310083904000_B8","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2020040310083904000_B9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.hoc.2019.04.001","article-title":"Burkitt lymphoma and other high-grade B-cell lymphomas with or without MYC, BCL2, and\/or BCL6 rearrangements","volume":"33","author":"Alsharif","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"issue":"16","key":"2020040310083904000_B10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1182\/blood-2017-02-767335","article-title":"Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets","volume":"130","author":"Bouska","year":"2017","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/14\/1078\/1722863\/bloodbld2020005329c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/14\/1078\/1722863\/bloodbld2020005329c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T14:09:39Z","timestamp":1585922979000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/14\/1078\/454164\/Tackling-Burkitt-when-its-back"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":10,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,4,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020005329","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2020,4,2]]}}}